Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger protein, transmembrane 1 pseudogene 2 (RNFT1P2) is a non-protein-coding pseudogene. While pseudogenes have historically been considered "junk DNA," recent research indicates that some can produce RNA transcripts with regulatory functions, such as acting as microRNA decoys or influencing RNA stability and translation in a tissue-specific manner[2][4]. However, RNFT1P2 itself is not known to encode a receptor, enzyme, or any active therapeutic target, and there is no evidence for direct disease association, clinical relevance, or drug interactions. The designation as a pseudogene implies that its sequence resembles that of a functional ring finger protein gene, but it cannot produce a functional protein product[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein, transmembrane 1 pseudogene 2 (RNFT1P2).